PEN.NYSEPenumbra INC

Form 4: Penumbra Inc. Executive Shiu Lambert Reports Stock Transactions

Sentiment:

SEC Form 4 Filing


Chief Accounting Officer Lambert Shiu reports stock transactions including option exercises and restricted stock unit grants.

Summary

  • Lambert Shiu, Chief Accounting Officer of Penumbra Inc., filed a Form 4 detailing changes in beneficial ownership of the company's stock.
  • On February 14, 2025, Shiu exercised stock options to acquire 4,525 shares at a price of $22.04.
  • Shiu also received 640 restricted stock units (RSUs) on February 14, 2025, which will vest in equal installments over four years.
  • On February 18, 2025, Shiu received an additional 1,510 RSUs, vesting annually beginning February 15, 2026.
  • 95 shares were withheld by Penumbra to cover tax obligations related to RSU vesting at a price of $271.14.
  • Following these transactions, Shiu directly owns 31,558 shares of Penumbra Inc. common stock, with an additional 300 shares held indirectly through a spouse's IRA.
  • Shiu also holds 9,200 derivative securities in the form of vested stock options.

Sentiment

Score: 6

Explanation: The sentiment is neutral. It's a routine filing of stock transactions. The exercise of options and granting of RSUs are standard compensation practices.

Positives

  • The exercise of stock options by a company executive can be seen as a positive sign, indicating confidence in the company's future performance.
  • The granting of RSUs aligns the executive's interests with those of the shareholders, incentivizing them to work towards the company's success.

Industry Context

Form 4 filings are a routine part of corporate governance, providing transparency into the trading activities of company insiders. These filings are closely watched by investors seeking insights into management's perspective on the company's stock.

Comparison to Industry Standards

  • Stock option and RSU grants are common compensation practices in the medical device industry, used to attract and retain talent.
  • Vesting schedules for RSUs typically range from three to five years, aligning with industry norms.
  • Companies like Medtronic and Boston Scientific also utilize similar equity-based compensation plans for their executives.

Stakeholder Impact

  • The transactions have a minor impact on shareholders, as they reflect standard executive compensation practices.
  • Employees may be indirectly affected by the executive's incentives to improve company performance.

Key Dates

DateDescription
02/14/2025Exercise of stock options for 4,525 shares and grant of 640 RSUs.
02/15/2026First vesting date for 1/4 of the 640 RSUs granted on 02/14/2025 and first vesting date for 1/4 of the 1,510 RSUs granted on 02/18/2025.
02/15/2027Second vesting date for 1/4 of the 640 RSUs granted on 02/14/2025.
02/15/2028Third vesting date for 1/4 of the 640 RSUs granted on 02/14/2025.
02/18/2025Grant of 1,510 RSUs.
02/19/2025Date of Form 4 filing.
08/11/2025Expiration date for the stock options exercised on 02/14/2025.

Keywords

Form 4, beneficial ownership, stock options, restricted stock units, RSUs, Penumbra Inc, Lambert Shiu, insider trading

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.